Naresh Tanna
Chief Financial Officer
Naresh is the Chief Financial Officer overseeing the Company’s finance and investor relations function. As Chief Financial Officer, he builds on his prior leadership as Vice President of Investor Relations and Chief of Staff to the CEO. Naresh joined Precision BioSciences in January 2022 and has been an integral member of the Senior Leadership Team, helping drive Precision’s corporate strategy and financings forward as it advanced its wholly owned in vivo gene editing programs.
He brings over 20 years of diverse experience across oncology, infectious diseases, and rare diseases spanning multiple treatment modalities. Before Precision, he held leadership roles in global oncology marketing and financial planning and analysis at Amgen, AbbVie, Celgene, and Lilly/ImClone, focusing on marketing, strategy, and execution across commercial and development-stage products. Earlier in his career, he held life sciences consulting roles at Trinity Partners and Clarkston Consulting.
Naresh holds an MBA from IESE Business School and a Bachelor of Science in Biomedical Engineering and Political Science from Rutgers School of Engineering. He also earned a Chief Financial Officer certificate from the executive program at The Wharton School of the University of Pennsylvania.